Clinical trials recruiting for Cardiotoxicity

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of Blood Pressure Control During Cancer Treatment
  NCT06023576 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 7 locations
• AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
  NCT06699056 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
  NCT05851053 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study
  NCT06595147 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: Female · 1 location
• Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure
  NCT04262830 · Phase: Not specified · Ages: 13 Years to 39 Years · Sex: All (male and female) · 1 location
• Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
  NCT03711110 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · 14 locations
• Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
  NCT06622954 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Global Cardio Oncology Registry
  NCT05598879 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
  NCT05406635 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: Female · 4 locations
• ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
  NCT07191730 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
  NCT06340516 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
  NCT05732051 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
  NCT07761910 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
  NCT03418961 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 590 locations
• Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
  NCT05465031 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · 8 locations
• Study on Proton Radiotherapy of Thymic Malignancies
  NCT04822077 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• The CARDIOPROTECT Trial
  NCT07654426 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial
  NCT05023785 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• The STOP-MED CTRCD Trial
  NCT06183437 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations

Related conditions

Trials recruiting for Cardiotoxicity often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Cardiotoxicity trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.